Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Consensus document issued on transcatheter heart valves. Boston Scientific launches Asia-Pacific organization. More news briefs.

You may also be interested in...



C.R. Bard Pays $48 Million To Settle Brachytherapy False Claims Act Allegations

The settlement addresses allegations by the Justice Department that the company provided kickbacks to Medicare customers and physicians from 1998 to 2006 to purchase brachytherapy seeds used to treat prostate cancer.

People In Brief

AliveCor names Judy Wade president and CEO. CooperVision and Boston Scientific make Asia Pacific appointments.

At AAOS, Makers Of Large Joint Implants Make It Personal

One attention-grabbing strategy at AAOS’ 2012 meeting centered on the personalization of large joint implants to match the specific anatomies of patients. Several large joint manufacturers have introduced tools for achieving “custom fits” for new joints, knees in particular.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT030943

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel